1. Home
  2. EDSA vs AEI Comparison

EDSA vs AEI Comparison

Compare EDSA & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • AEI
  • Stock Information
  • Founded
  • EDSA 2015
  • AEI 2014
  • Country
  • EDSA Canada
  • AEI United States
  • Employees
  • EDSA N/A
  • AEI N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • AEI Building operators
  • Sector
  • EDSA Health Care
  • AEI Real Estate
  • Exchange
  • EDSA Nasdaq
  • AEI Nasdaq
  • Market Cap
  • EDSA 17.2M
  • AEI 13.6M
  • IPO Year
  • EDSA N/A
  • AEI N/A
  • Fundamental
  • Price
  • EDSA $2.40
  • AEI $3.21
  • Analyst Decision
  • EDSA Strong Buy
  • AEI
  • Analyst Count
  • EDSA 2
  • AEI 0
  • Target Price
  • EDSA $13.00
  • AEI N/A
  • AVG Volume (30 Days)
  • EDSA 16.6K
  • AEI 1.3M
  • Earning Date
  • EDSA 08-08-2025
  • AEI 11-13-2025
  • Dividend Yield
  • EDSA N/A
  • AEI N/A
  • EPS Growth
  • EDSA N/A
  • AEI N/A
  • EPS
  • EDSA N/A
  • AEI N/A
  • Revenue
  • EDSA N/A
  • AEI $16,069,911.00
  • Revenue This Year
  • EDSA N/A
  • AEI N/A
  • Revenue Next Year
  • EDSA N/A
  • AEI N/A
  • P/E Ratio
  • EDSA N/A
  • AEI N/A
  • Revenue Growth
  • EDSA N/A
  • AEI 74.28
  • 52 Week Low
  • EDSA $1.55
  • AEI $0.70
  • 52 Week High
  • EDSA $5.00
  • AEI $3.79
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 53.67
  • AEI 65.50
  • Support Level
  • EDSA $2.41
  • AEI $2.21
  • Resistance Level
  • EDSA $2.48
  • AEI $3.79
  • Average True Range (ATR)
  • EDSA 0.09
  • AEI 0.51
  • MACD
  • EDSA -0.01
  • AEI 0.16
  • Stochastic Oscillator
  • EDSA 51.85
  • AEI 76.80

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

Share on Social Networks: